Santa Fe, New Mexico, December 1, 2020 — Specifica, a company revolutionizing antibody discovery, today announced that it has delivered an exclusive antibody library platform to UCB, a global biopharmaceutical…
FDM DigitalDecember 1, 2020
Company’s Generation 3 Antibody Platform Delivers High-Affinity, Drug-Like Antibody Candidates Well Designed to Facilitate the Development of High-Quality Therapeutics Santa Fe, New Mexico, May 12, 2020 — Specifica, a leading…
FDM DigitalMay 12, 2020
Specifica CSO, Andrew Bradbury, participates in this Miltenyi webcast on the importance of recombinant antibodies.Read the full article HERE.
FDM DigitalJune 3, 2018
